TELANGIECTATIC CAPILLARIES CAUSING PERSISTENT DIABETIC MACULAR EDEMA SUCCESSFULLY TREATED BY PHOTODYNAMIC THERAPY.

Q3 Medicine

Retinal Cases and Brief Reports Pub Date : 2024-09-01 DOI:10.1097/ICB.0000000000001446

Marion Schaeffer, Léa Dormegny, Claude Speeg-Schatz, Arnaud Sauer, Tristan Bourcier, David Gaucher

{"title":"TELANGIECTATIC CAPILLARIES CAUSING PERSISTENT DIABETIC MACULAR EDEMA SUCCESSFULLY TREATED BY PHOTODYNAMIC THERAPY.","authors":"Marion Schaeffer, Léa Dormegny, Claude Speeg-Schatz, Arnaud Sauer, Tristan Bourcier, David Gaucher","doi":"10.1097/ICB.0000000000001446","DOIUrl":null,"url":null,"abstract":"Purpose: To report two cases of persistent macular edema caused by the exudation of diabetic telangiectatic capillaries (TelCaps), which have been successfully treated with photodynamic therapy (PDT).Methods: Review of data from two patients suffering from persistent macular edema caused by parafoveolar TelCaps. In both cases, conventional laser was impossible because TelCaps were to close from foveal center.Results: The use of focal PDT on perifoveolar TelCaps permitted to reduce persistent macular edema and to avoid inefficient intravitreal anti-vascular epithelial growth factor or steroid injections. In both cases, visual acuity was fully restored four to six months after PDT. Central macular thickness was also normalized in the first case and significantly reduced in the second case. In both cases, visual gain was sustained throughout the whole follow-up period (2 and 1 year, respectively).Conclusion: Photodynamic therapy can be helpful to treat diabetic macular edema caused by TelCaps nonresponding to approved intravitreal therapy or for which conventional laser is contraindicated.","PeriodicalId":53580,"journal":{"name":"Retinal Cases and Brief Reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retinal Cases and Brief Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICB.0000000000001446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To report two cases of persistent macular edema caused by the exudation of diabetic telangiectatic capillaries (TelCaps), which have been successfully treated with photodynamic therapy (PDT).

Methods: Review of data from two patients suffering from persistent macular edema caused by parafoveolar TelCaps. In both cases, conventional laser was impossible because TelCaps were to close from foveal center.

Results: The use of focal PDT on perifoveolar TelCaps permitted to reduce persistent macular edema and to avoid inefficient intravitreal anti-vascular epithelial growth factor or steroid injections. In both cases, visual acuity was fully restored four to six months after PDT. Central macular thickness was also normalized in the first case and significantly reduced in the second case. In both cases, visual gain was sustained throughout the whole follow-up period (2 and 1 year, respectively).

Conclusion: Photodynamic therapy can be helpful to treat diabetic macular edema caused by TelCaps nonresponding to approved intravitreal therapy or for which conventional laser is contraindicated.

查看原文本刊更多论文

光动力疗法成功治疗了导致持续性糖尿病黄斑水肿的毛细血管扩张。

目的：报告两例因糖尿病毛细血管扩张（TelCaps）引起的持续性黄斑水肿病例，这两例病例已成功接受光动力疗法（PDT）治疗：方法：回顾两名因眼窝旁毛细血管扩张引起的持续性黄斑水肿患者的数据。在这两个病例中，由于TelCaps距离眼窝中心太近，无法进行常规激光治疗：结果：对叶周TelCaps使用局灶性PDT可以减轻持续性黄斑水肿，避免无效的玻璃体内抗血管上皮生长因子或类固醇注射。在这两个病例中，视力在光动力疗法后四到六个月完全恢复。第一个病例的黄斑中心厚度也恢复正常，第二个病例的黄斑中心厚度则显著减少。两例患者在整个随访期间（分别为 2 年和 1 年）都保持了视力的提高：结论：光动力疗法有助于治疗对已获批准的玻璃体内疗法无效或禁用传统激光的 TelCaps 所引起的糖尿病性黄斑水肿。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Retinal Cases and Brief Reports Medicine-Ophthalmology

CiteScore

2.10

自引率

0.00%

发文量

342